EXCELINDUSNSEExcel Industries Limited· Chemicals & PetrochemicalsHighNeutral
Announced Fri, 8 Aug, 2025 · 18:27 IST

Excel Industries Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.

EXCELINDUS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+4.7%Reaction day
₹1161.50
prior close
₹1234.00
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.2%+4.5% vs market
Specialty Chemicals peers, median of 84sector-0.3%+5.0% vs sector

On the reaction day the stock moved 4.5 pts more than Nifty Microcap 250 and 5.0 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.2
10m
+0.0
15m
-2.5
30m
-1.9
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+4.7+0.2+4.5-0.3+5.0
Next day
+7.4+0.2+7.2-0.5+7.8
2d
+7.3+0.9+6.5+0.0+7.3
3d
+4.9+0.1+4.9+0.2+4.7
4d
+0.9+1.6-0.7+0.4+0.5
5d
+5.5+2.8+2.7+1.3+4.2
1w
+12.8+3.0+9.7+1.0+11.8
15d
+3.3+2.8+0.5+1.0+2.3
1m
-0.6+3.1-3.7+0.0-0.6
2m
-1.1+1.4-2.5-1.8+0.8
3m
-8.0+1.4-9.4-4.5-3.5
UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 84Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Excel Industries announced its unaudited Q1 FY26 results (quarter ended June 30, 2025), reviewed by Price Waterhouse Chartered Accountants LLP with an unmodified conclusion. Standalone revenue from operations was Rs. 30,947 lakhs, up about 24.9% sequentially from Rs. 24,784 lakhs in Q4 FY25 and roughly 16.8% higher year-on-year versus Rs. 26,491 lakhs in Q1 FY25. Standalone profit after tax rose sharply to Rs. 3,356 lakhs from Rs. 1,137 lakhs in Q4 FY25, but only modestly versus Rs. 3,148 lakhs in Q1 FY25. Basic and diluted EPS stood at Rs. 26.70, compared to Rs. 25.04 a year ago. Consolidated results were broadly similar, with revenue of Rs. 30,952 lakhs and PAT of Rs. 3,376 lakhs. The company also noted it has simplified segment reporting to a single 'Chemicals' segment following an internal reorganization. A large fair-value gain on equity instruments drove total comprehensive income to Rs. 13,633 lakhs on a consolidated basis.

Likely market impact

The results show a strong sequential bounce-back after a weak Q4 FY25 and continued high-teens revenue growth, which is positive for shareholders. However, year-on-year profit growth is muted, indicating margin pressure despite higher revenues. The clean auditor review and no flagged concerns support investor confidence.